Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.

Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedFooter revision label updated from v3.6.2 to v3.6.3, indicating a minor site revision. This change reflects an update to the page's version tag rather than any alteration to the study content or details.SummaryDifference0.0%

- Check23 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a small maintenance update to the page version. This does not alter trial data or visible content.SummaryDifference0.0%

- Check38 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' indicating that enrollment is closed. New help and navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment label was standardized, with the revision notice updated to v3.6.0.SummaryDifference0.4%

- Check45 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a minor system update; the study details and user-facing content appear unchanged.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, indicating a new build or update. No study content or data appears to be changed by this update.SummaryDifference0.0%

- Check81 days agoChange DetectedA new revision tag (v3.5.3) replaces the previous tag (v3.5.2), signaling an update to the page's version.SummaryDifference0.0%

Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.